American Renal Associates Holdings, Inc. revenue reports
American Renal Associates Holdings, Inc. financial reports, American Renal Associates Holdings, Inc. annual revenue in 2024. When does American Renal Associates Holdings, Inc. report revenue?
American Renal Associates Holdings, Inc. total revenue, net income and dynamics of changes in US dollar today
American Renal Associates Holdings, Inc. current income in US dollar. Net revenue of American Renal Associates Holdings, Inc. on 30/09/2019 amounted to 211 429 000 $. American Renal Associates Holdings, Inc. net income is now 4 777 000 $. The financial report schedule from 31/12/2017 to 30/09/2019 is available online. All information on American Renal Associates Holdings, Inc. total revenue on this chart is created in the form of yellow bars. The value of American Renal Associates Holdings, Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019
211 429 000 $
+0.19 % ↑
4 777 000 $
+91.85 % ↑
30/06/2019
213 252 000 $
-1.8077 % ↓
-8 178 000 $
-
31/03/2019
191 762 000 $
-1.495 % ↓
-10 479 000 $
-
31/12/2018
182 907 000 $
-5.9014 % ↓
-12 339 000 $
-5441.558 % ↓
30/09/2018
211 019 000 $
-
2 490 000 $
-
30/06/2018
217 178 000 $
-
-18 008 000 $
-
31/03/2018
194 672 000 $
-
-910 000 $
-
31/12/2017
194 378 000 $
-
231 000 $
-
Show:
to
American Renal Associates Holdings, Inc. financial report charts
Dates of American Renal Associates Holdings, Inc. finance reports: 31/12/2017, 30/06/2019, 30/09/2019. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of American Renal Associates Holdings, Inc. is 30/09/2019. Gross profit American Renal Associates Holdings, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit American Renal Associates Holdings, Inc. is 56 841 000 $
American Renal Associates Holdings, Inc. quarterly report dates
Cost of revenue American Renal Associates Holdings, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue American Renal Associates Holdings, Inc. is 154 588 000 $ Total revenue American Renal Associates Holdings, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue American Renal Associates Holdings, Inc. is 211 429 000 $ Operating revenue American Renal Associates Holdings, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue American Renal Associates Holdings, Inc. is 211 429 000 $
Operating income American Renal Associates Holdings, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income American Renal Associates Holdings, Inc. is 28 538 000 $ Net income American Renal Associates Holdings, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income American Renal Associates Holdings, Inc. is 4 777 000 $ Current assets American Renal Associates Holdings, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets American Renal Associates Holdings, Inc. is 212 435 000 $
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
56 841 000 $
65 889 000 $
54 049 000 $
32 491 000 $
65 719 000 $
76 616 000 $
60 941 000 $
69 904 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
154 588 000 $
147 363 000 $
137 713 000 $
150 416 000 $
145 300 000 $
140 562 000 $
133 731 000 $
124 474 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
211 429 000 $
213 252 000 $
191 762 000 $
182 907 000 $
211 019 000 $
217 178 000 $
194 672 000 $
194 378 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
211 429 000 $
213 252 000 $
191 762 000 $
182 907 000 $
211 019 000 $
217 178 000 $
194 672 000 $
194 378 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
28 538 000 $
26 010 000 $
7 916 000 $
-2 570 000 $
31 077 000 $
39 999 000 $
26 358 000 $
37 466 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
4 777 000 $
-8 178 000 $
-10 479 000 $
-12 339 000 $
2 490 000 $
-18 008 000 $
-910 000 $
231 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
182 891 000 $
187 242 000 $
183 846 000 $
185 477 000 $
179 942 000 $
177 179 000 $
168 314 000 $
156 912 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
212 435 000 $
230 079 000 $
198 134 000 $
194 863 000 $
184 764 000 $
192 497 000 $
189 961 000 $
187 591 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 117 945 000 $
1 147 423 000 $
1 134 177 000 $
985 843 000 $
967 063 000 $
975 669 000 $
969 784 000 $
964 208 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
60 190 000 $
69 060 000 $
64 871 000 $
55 200 000 $
61 872 000 $
69 403 000 $
64 283 000 $
71 521 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
211 262 000 $
222 613 000 $
209 285 000 $
197 640 000 $
179 040 000 $
179 351 000 $
165 120 000 $
156 903 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
908 850 000 $
934 174 000 $
902 753 000 $
746 833 000 $
724 487 000 $
733 886 000 $
710 319 000 $
703 828 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
81.30 %
81.41 %
79.60 %
75.76 %
74.92 %
75.22 %
73.25 %
73 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-75 762 000 $
-81 482 000 $
-71 576 000 $
-58 970 000 $
-73 529 000 $
-72 378 000 $
-55 413 000 $
-56 778 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
27 355 000 $
17 741 000 $
-9 993 000 $
22 533 000 $
25 392 000 $
37 470 000 $
21 009 000 $
31 175 000 $
Last revenue report of American Renal Associates Holdings, Inc. was 30/09/2019. According to last financial report total revenue in American Renal Associates Holdings, Inc. was 211 429 000 US dollar and changed by +0.19% since last year. Net income in American Renal Associates Holdings, Inc. was 4 777 000 $ in last quartal, net income changes to +91.85%.
Total assets American Renal Associates Holdings, Inc. refers to the total amount of assets owned by a person or entity. Total assets American Renal Associates Holdings, Inc. is 1 117 945 000 $ Current cash American Renal Associates Holdings, Inc. - the sum of all of the cash a company has on the date of report. Current cash American Renal Associates Holdings, Inc. is 60 190 000 $ Current debt American Renal Associates Holdings, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt American Renal Associates Holdings, Inc. is 211 262 000 $
American Renal Associates Holdings, Inc. stocks data
ARA stock price
American Renal Associates Holdings, Inc. stock price today, ARA stock quote.
